Regintel LimitedBranch (foreign co.)
Research and experimental development on biotechnology
KRS: REGON:
Overview
Status
Active
Registry date
2022-05-16
Registered address
ul. Krucza 16/22, 00-526 Warszawa, Poland
Authorized Representatives
Patrick Kennedy Martin – Dyrektor
Vanessa Marion Price – Dyrektor
Manner of representation
Independent representation.
Beneficial owners
No beneficial owners recorded for the branch Regintel Limited.
Debt
No entries in the National Debtors Register (KRZ).
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | ||
| FamicordtxS.A. | $589,673.84 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Neobiolabsp. z o.o. | $1,185.42 | neobiolab.pl |
FAQ
The main business activity of Regintel Limited focuses on research and experimental development on biotechnology.
The business was registered in the Polish National Court Register (KRS) on May 16, 2022.
The headquarters is located at: ul. Krucza 16, 00-526 Warszawa.
The legal form of this entity is a branch of a foreign entrepreneur.
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-10-07